Michael Dybbs

Insider Reports History

Location
San Mateo, CA
Signature
/s/ David Pauling as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Dybbs:

Company Role Class Num Shares Value Price $ Report Date Ownership
Nkarta, Inc. Director Stock Option (right to buy) 46,000 05 Jun 2025 Direct
Kalaris Therapeutics, Inc. Director Stock Option (Right to Buy) 18,000 10 Apr 2025 Direct
SUTRO BIOPHARMA, INC. Director Stock Option (right to buy) 1,500 23 Dec 2025 Direct

Insider Reports Filed by Michael Dybbs

Symbol Company Period Transactions Value $ Form Type Role Filing Time
STRO SUTRO BIOPHARMA, INC. 23 Dec 2025 1 $0 4 Director 29 Dec 2025, 16:54
STRO SUTRO BIOPHARMA, INC. 06 Jun 2025 1 $0 4 Director 10 Jun 2025, 16:08
NKTX Nkarta, Inc. 05 Jun 2025 1 $0 4 Director 09 Jun 2025, 16:00
KLRS Kalaris Therapeutics, Inc. 10 Apr 2025 1 $0 4 Director 11 Apr 2025, 16:59
KLRS Kalaris Therapeutics, Inc. 18 Mar 2025 0 $0 3 Director 18 Mar 2025, 17:25
NKTX Nkarta, Inc. 13 Jun 2024 1 $0 4 Director 14 Jun 2024, 16:08
STRO SUTRO BIOPHARMA, INC. 06 Jun 2024 1 $0 4 Director 10 Jun 2024, 16:19
STRO SUTRO BIOPHARMA, INC. 08 Jun 2023 1 $0 4 Director 12 Jun 2023, 18:30
NKTX Nkarta, Inc. 07 Jun 2023 1 $0 4 Director 09 Jun 2023, 16:06
NKTX Nkarta, Inc. 08 Jun 2022 1 $0 4 Director 10 Jun 2022, 16:06
STRO SUTRO BIOPHARMA, INC. 06 Jun 2022 1 $0 4 Director 08 Jun 2022, 19:05
NKTX Nkarta, Inc. 13 Jun 2021 1 $0 4 Director 15 Jun 2021, 10:29
STRO SUTRO BIOPHARMA, INC. 03 Jun 2021 1 $0 4 Director 07 Jun 2021, 17:02